Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma
Junichi Inokuchi, Masatoshi EtoDepartment of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanAbstract: The prognosis of patients with unresectable or metastatic urothelial carcinoma (UC) is poor. Platinum-based chemotherapy has been the standard first-line treatment in...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-05-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/profile-of-pembrolizumab-in-the-treatment-of-patients-with-unresectabl-peer-reviewed-article-CMAR |